Weaver C. Barksdale & Associates’s Emerson Electric EMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$1.66M Sell
23,827
-381
-2% -$24.7K 1.75% 15
2017
Q3
$1.52M Hold
24,208
1.7% 17
2017
Q2
$1.44M Hold
24,208
1.68% 21
2017
Q1
$1.45M Buy
24,208
+6,720
+38% +$401K 1.71% 14
2016
Q4
$975K Buy
17,488
+1,240
+8% +$66.7K 1.57% 24
2016
Q3
$886K Sell
16,248
-545
-3% -$29.2K 1.49% 31
2016
Q2
$876K Hold
16,793
1.52% 32
2016
Q1
$913K Buy
16,793
+7,222
+75% +$348K 0.69% 44
2015
Q4
$458K Hold
9,571
0.36% 85
2015
Q3
$423K Hold
9,571
0.34% 88
2015
Q2
$531K Hold
9,571
0.39% 86
2015
Q1
$542K Hold
9,571
0.41% 84
2014
Q4
$591K Hold
9,571
0.48% 83
2014
Q3
$599K Hold
9,571
0.49% 80
2014
Q2
$635K Hold
9,571
0.51% 76
2014
Q1
$639K Sell
9,571
-1,175
-11% -$77.3K 0.53% 74
2013
Q4
$754K Sell
10,746
-48
-0.4% -$3.21K 0.63% 46
2013
Q3
$698K Buy
10,794
+5,350
+98% +$327K 0.64% 43
2013
Q2
$297K Buy
+5,444
New +$306K 0.29% 77

Other funds holding EMR

Weaver C. Barksdale & Associates's EMR Position: Q4 2017 in Review

Weaver C. Barksdale & Associates reduced its Emerson Electric (EMR) stake by 1.6% in Q4 2017, selling an estimated $24.7K and leaving 23,827 shares worth $1.66M. The position accounts for 1.75% of the portfolio, ranked #15.

Weaver C. Barksdale & Associates first reported a position in EMR in Q2 2013 and has held it in 19 quarters since. 1,373 funds tracked by Wall St. Rank hold EMR as of Q4 2017.

  • Weaver C. Barksdale & Associates held 23,827 shares of Emerson Electric worth $1.66M as of Q4 2017.
  • Weaver C. Barksdale & Associates sold 381 Emerson Electric shares in Q4 2017, an estimated $24.7K.
  • Emerson Electric made up 1.75% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #15 holding.
  • Weaver C. Barksdale & Associates first reported a position in Emerson Electric in Q2 2013 and has held it in 19 quarters since.
  • 1,373 funds tracked by Wall St. Rank held Emerson Electric as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.